First-in-Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Oral Doses of BIIB091, an Oral BTK Inhibitor, in Healthy Adult Participants.
Tsai H-H, Gu Y, Riester K, Chu SS, Bame E, Arefayene M, Kam JLYL, Coppell A, Hanna J, Hopkins BT, et al.
Drug Des Devel Ther. 2026; 20:571780. PMID: 42016388.Abstract
